新诊断的炎症性肠病患者的综合蛋白质组概况:识别潜在的生物标志物
Montse Baldán-Martín1, Ibon Iloro2, Mikel Azkargorta2
1Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa (IIS-Princesa), Universidad Autónoma de Madrid (UAM), and Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas (CIBEREHD), Madrid, Spain.
Journal of Crohn's & colitis
|October 9, 2025
概括
这项研究确定了炎症性肠病 (IBD) 患者血液和组织中的新型蛋白质生物标志物. 这些发现可能有助于区分克罗恩氏病 (CD) 和性结肠炎 (UC),并了解疾病机制.
科学领域:
- 蛋白质组学是指蛋白质组学.
- 生物标志物发现发现
- 胃肠病学 胃肠病学
背景情况:
- 炎症性肠病 (IBD),包括克罗恩病 (CD) 和性结肠炎 (UC),存在诊断方面的挑战.
- 在早期IBD中识别不同的蛋白质组签名可能会阐明疾病机制并有助于差异诊断.
研究的目的:
- 为了确定治疗先前的IBD患者的蛋白质组概况.
- 发现潜在的蛋白质生物标志物,以区分CD和UC.
- 为了深入了解IBD的病理生理学.
主要方法:
- 在100名IBD患者 (50CD,50UC) 和51名健康对照者的血清细胞外囊泡 (EVs),血清,尿液和肠道组织上使用了无标签的定量蛋白质组学.
- 用ELISA验证了候选血清生物标志物.
- 在肠道活检上进行了免疫组织化学检查,以确认蛋白质表达模式.
主要成果:
- 蛋白质组分析在所有样本类型中确定了许多蛋白质.
- 与HC相比,ELISA揭示了UC患者的TTR,APOC3和ATRN水平的差异,并在CD患者中改变了TTR和ATRN.
- 血清蛋白S10A9在CD与UC上升调节,免疫组织化学显示了IBD亚型中PRDX4,AZU1和AOFB的明显表达模式.
结论:
- 这项研究确定了IBD中差异表达的蛋白质,提供了作为候选生物标记物的潜力.
- 这些蛋白质组发现有助于理解IBD机制.
- 需要进一步的研究来验证这些初步发现的诊断和治疗应用.
相关概念视频
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
637
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
637
01:27Inflammatory Bowel Disease I: Ulcerative Colitis
894
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
894
01:30Inflammatory Bowel Disease II: Crohn's Disease
952
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
952
01:29Inflammatory Bowel Disease IV: Pharmacological Management
517
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
517
01:17Chronic Bowel Disorders: Introduction
746
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
746
01:30Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
729
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
729